Klaas Bjoern's most recent trade in Proto Labs Inc was a trade of 6,713 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 6,713 | 23,046 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | Klaas Bjoern | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 6,182 | 6,182 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Klaas Bjoern | VP and Mng Director-PL Europe | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.52 per share. | 13 Feb 2024 | 1,741 | 16,333 (0%) | 0% | 33.5 | 58,358 | Common Stock |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 6,649 | 18,074 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 6,310 | 6,310 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 3,325 | 3,325 | - | - | Performance Stock Units | |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 3,048 | 3,048 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.23 per share. | 13 Feb 2023 | 1,119 | 11,425 (0%) | 0% | 34.2 | 38,303 | Common Stock |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 4,042 | 4,042 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 3,788 | 12,544 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,894 | 1,894 | - | - | Performance Stock Units | |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.34 per share. | 13 Feb 2022 | 728 | 8,756 (0%) | 0% | 56.3 | 41,016 | Common Stock |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,365 | 9,484 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,826 | 1,826 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Payment of exercise price or tax liability using portion of securities received from the company at price $ 197.05 per share. | 16 Feb 2021 | 455 | 7,119 (0%) | 0% | 197.1 | 89,658 | Common Stock |
| Proto Labs Inc | Bjoern Klaas | VP and Mng Director-PL Europe | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.34 per share. | 01 Dec 2020 | 489 | 7,574 (0%) | 0% | 136.3 | 66,670 | Common Stock |